Home
 /
Papers
 /
Genomics
 /
MERFISH+, a large-scale, multi-omics spatial technology resolves the molecular holograms of the 3D human developing heart
Preprint
Open access
V1
Top 1% · Validated by QED

MERFISH+, a large-scale, multi-omics spatial technology resolves the molecular holograms of the 3D human developing…

Colin Kern, Qingquan Zhang, Yifan Lu +21 more
November 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.11.02.686137
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Genomics this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By scaling spatial multi-omics to an entire organ at subcellular resolution, MERFISH+ shatters prior 2D and size constraints, producing the first 3D molecular atlas of a developing human heart and making whole-organ spatial biology tractable.

QED claims analysis

Summary

MERFISH+ technology, which covalently anchors fluorescent probes to polyacrylamide hydrogels enabling stable multi-month imaging, facilitates the reconstruction of the first comprehensive 3D molecular atlas of an entire developing human organ at single-cell resolution, profiling over 1,800 genes and multimodal epigenetic features across 3.1 million cells to reveal cellular neighborhoods, spatial expression gradients, and cell-cell signaling patterns that govern cardiac morphogenesis and coronary artery development.

See full analysis
Main Claim 1 –

Acrydite-anchored MERFISH probes enable extended stable spatial imaging

Supporting evidence

  • MERFISH+ scales to 1,800 genes revealing new populations
  • MERFISH+ enables multimodal RNA, chromatin, and epigenetic imaging
Main Claim 2 –

MERFISH+ reconstructs whole-organ 3D developing heart atlas

Supporting evidence

  • 3D heart atlas reveals neighborhoods and coronary gradients
  • Spateo-VI integrates 2D multimodal data into 3D atlas

Abstract

Hybridization-based spatial transcriptomics technologies have advanced our ability to map cellular and subcellular organization in complex tissues. However, existing methods remain constrained in gene coverage, multimodal compatibility, and scalability. Here, we present MERFISH+, an enhanced version of Multiplexed Error-Robust Fluorescence in Situ Hybridization (MERFISH), which integrates chemical probe anchoring in protective hydrogels with high-throughput microfluidics and microscopy. This optimized design supports robust and repeated hybridization cycles across an entire centimeter-scale tissue sample. MERFISH+ allowed to simultaneously quantify over 1,800 genes and resolve the 3D organization of chromatin loci and their associated epigenomic marks in developing human hearts. Using a generative integration framework for spatial multimodal data (Spateo-VI), we harmonized these MERFISH+ transcriptomic and chromatin data to reconstruct a 3D spatially-resolved multi-omic atlas of the developing human heart at subcellular resolution capturing 3.1 million cells across 34 distinct populations. This 3D atlas provides a holistic view of an entire organ enabling the characterization of 3D cellular neighborhoods and transcriptional gradients of substructures such as the descending arteries. Thus, MERFISH+ offers a robust, large-format platform for spatial multi-omics that enables high resolution mapping of gene expression at subcellular resolution and the characterization of cellular organization within 3D organs.

MERFISH+ is an spatial multi-omics platform that integrates hydrogel-based probe anchoring, automated high-throughput microfluidics, and large-format multimodal data production to enable comprehensive, subcellular resolution mapping of gene expression and chromatin organization across millions of cells within complex developing human organs.

Highlights

MERFISH+ expands MERFISH capabilities to measure >1,800 genes and at whole-organ 3D imaging scale

Combines chemical probe anchoring with high-throughput volumetric microscopy and microfluidics

Generates a 3D molecular atlas of a developing human heart with > 3.1 million cells at subcellular resolution

Introduces Spateo-VI, a novel generative framework integrating 3D multimodal datasets

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?